News Daily News Newest Atherosclerosis Risk Calculator Aims to Adjust Predictions as Prevention Tactics Kick In Yael L. Maxwell November 10, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2016 Caitlin E. Cox October 29, 2016
News Daily News Midlife Hypertension Linked to Late-Life Cognitive Decline Leah Lawrence October 11, 2016
News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Daily News Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients Michael O'Riordan August 16, 2016
News Daily News USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents Michael O'Riordan August 09, 2016
News Daily News Timing and Type of Events Post-PCI Have Implications for Prognosis—and Honest Discussions With Patients Yael L. Maxwell July 05, 2016
News Daily News Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel Michael O'Riordan June 09, 2016
News Conference News EAS 2016 Preservation of LDL Cholesterol Targets for Lipid Lowering in New European Guidance Gets Blessing of Prevention Experts Yael L. Maxwell June 06, 2016
News Conference News EAS 2016 Statin-Associated Muscle Symptoms: Real or ‘Artificial,’ Physicians Should Take Time to Manage Patients Yael L. Maxwell June 01, 2016
News Daily News Survey Adds To Mounting Evidence That Cath Lab Work Has Radiation-Related Health Effects L.A. McKeown April 14, 2016
News Industry News Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection July 09, 2015
News Industry News Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease June 05, 2015